Mary T. Brophy, MD
Assistant Professor, Medicine
Other Positions
- Member, BU-BMC Cancer Center, Boston University
- VA Boston Healthcare System
Education
- Tufts University School of Medicine, MD
- Stonehill College, BS
Publications
- Published on 1/30/2025
Swinnerton K, Fillmore NR, Oboho I, Grubber J, Brophy M, Do NV, Monach PA, Branch-Elliman W. Pulmonary aspergillosis in US Veterans with COVID-19: a nationwide, retrospective cohort study. Antimicrob Steward Healthc Epidemiol. 2025; 5(1):e28. PMID: 39911504.
Read at: PubMed - Published on 1/14/2025
Ferri GM, Yildirim C, Do NV, Brophy M, Park JS, Munshi NC, Fillmore NR, Edwards CV. Lymphopenia predicts poor outcomes in newly diagnosed multiple myeloma. Blood Adv. 2025 Jan 14; 9(1):78-88. PMID: 39471425.
Read at: PubMed - Published on 12/30/2024
Wu JT, Corrigan J, Su C, Dumontier C, La J, Khan A, Arya S, Harris AHS, Backhus L, Das M, Do NV, Brophy MT, Han SS, Kelley M, Fillmore NR. Correction: The performance status gap in immunotherapy for frail patients with advanced non-small cell lung cancer. Cancer Immunol Immunother. 2024 Dec 30; 74(1):34. PMID: 39739108.
Read at: PubMed - Published on 12/23/2024
Lee MH, La J, Brophy MT, Do NV, Edwards CV, DuMontier C, Hobbs GS, Fillmore NR. Psychiatric and substance use disorders predict poor outcomes in older veterans with acute myeloid leukemia. Blood Adv. 2024 Dec 23. PMID: 39715463.
Read at: PubMed - Published on 12/16/2024
Larsen JR, Zheng C, La J, Wu JT, Kelley M, Gaziano JM, Brophy M, Do NV, Kim DH, Driver JA, Dumontier C, Fillmore NR. Multimorbidity and Its Impact in Older United States Veterans Newly Treated for Advanced Non-Small Cell Lung Cancer. Ann Am Thorac Soc. 2024 Dec 16. PMID: 39680869.
Read at: PubMed - Published on 12/3/2024
Dulberger KN, La J, Li A, Lotfollahzadeh S, Jose A, Do NV, Brophy MT, Gaziano JM, Ravid K, Chitalia VC, Fillmore NR. External validation of a novel cancer-associated venous thromboembolism risk assessment score in a safety-net hospital. Res Pract Thromb Haemost. 2025 Jan; 9(1):102650. PMID: 39839661.
Read at: PubMed - Published on 8/1/2024
La J, Wang L, Corrigan JK, Lang D, Lee MH, Do NV, Brophy MT, Paller CJ, Fillmore NR. Abiraterone or Enzalutamide for Patients With Metastatic Castration-Resistant Prostate Cancer. JAMA Netw Open. 2024 Aug 01; 7(8):e2428444. PMID: 39150709.
Read at: PubMed - Published on 7/15/2024
Barry A, Helget LN, Androsenko M, Wu H, Kramer B, Newcomb JA, Brophy MT, Davis-Karim A, England BR, Ferguson R, Pillinger MH, Neogi T, Palevsky PM, Merriman TR, O'Dell JR, Mikuls TR. Comparison of Gout Flares With the Initiation of Treat-to-Target Allopurinol and Febuxostat: A Post-Hoc Analysis of a Randomized Multicenter Trial. Arthritis Rheumatol. 2024 Oct; 76(10):1552-1559. PMID: 38925627.
Read at: PubMed - Published on 7/2/2024
Kim RB, Zhou E, Swinnerton KN, La J, Ma S, Ranjan M, Do NV, Brophy MT, Fillmore NR, Li A. Racial and Ethnic Disparity for Cancer Mortality in General and Single-Payer Healthcare Systems in the United States. J Racial Ethn Health Disparities. 2024 Jul 02. PMID: 38955957.
Read at: PubMed - Published on 7/2/2024
Wu JT, Corrigan J, Su C, Dumontier C, La J, Khan A, Arya S, Harris AHS, Backhus L, Das M, Do NV, Brophy MT, Han SS, Kelley M, Fillmore NR. The performance status gap in immunotherapy for frail patients with advanced non-small cell lung cancer. Cancer Immunol Immunother. 2024 Jul 02; 73(9):172. PMID: 38954019.
Read at: PubMed
View 108 more publications: View full profile at BUMC